Extracellular vesicle–mediated gene editing for the treatment of nonsyndromic progressive hearing loss in adult mice
Science Translational Medicine · 12.11.2025 · 17 (824)
DOI: 10.1126/scitranslmed.adn3993 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 12.11.2025. Verfasst von Xiaoshu Pan und 12 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Department of Pharmaceutics, University of Florida, Gainesville, FL 32611, USA. Hauptthemen laut MEDLINE: Extracellular Vesicles, Gene Editing, Hearing Loss. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, CFF.
Abstract (Originalsprache)
The clinical translation of gene therapy has been challenging in part because of the limitations of current delivery approaches. Herein, we report an efficient nonviral genome editor delivery approach using extracellular vesicles (EVs) carrying single-guide RNA (sgRNA): CRISPR-Cas9 ribonucleoprotein (RNP) complexes for in vivo gene therapy. By leveraging a high-throughput microfluidic droplet–based electroporation system (μDES), we achieved a 10-fold enhancement in loading efficiency and more than 1000-fold increase in processing throughput for loading RNP complexes into EVs compared with conventional high-voltage pulsed electroporation. μDES generated uniform microdroplets containing EVs and RNPs by applying direct current–controlled low voltage (up to 60 V) to transiently permeabilize membranes and enable efficient cargo encapsulation while maintaining EV integrity at both the protein and morphological levels. In the Myo7a WT/Sh1 mouse model of autosomal dominant progressive hearing loss, which may model MYO7A-associated DFNA11 hearing loss in humans, we demonstrated the effective delivery of RNPs by EVs into cochlear hair cells by cross-sectional and whole-mount confocal imaging. The injection of RNP-EVs via the posterior semicircular canal in 4-week-old Myo7a WT/Sh1 mice resulted in a reduction in Myo7a Sh1 messenger RNA expression and evidence of hearing preservation, as measured by auditory brainstem responses, compared with untreated ears and EV only–injected mice. This study highlights the potential of μDES-produced RNP-EVs for gene editing as a treatment for progressive nonsyndromic hearing loss in patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Department of Pharmaceutics, University of Florida, Gainesville, FL 32611, USA.
- Department of Otolaryngology, Head and Neck Surgery, University of Kansas School of Medicine, Kansas City, KS 66160, USA.
- Department of Medicinal Chemistry, Center for Natural Products, Drug Discovery, and Development, University of Florida, Gainesville, FL 32610, USA.
- Department of Otolaryngology, Hannover Medical School, 30625 Hannover, Germany.
ORCID-Profile: Xiaoshu Pan, Samantha S Ali, Zachary Greenberg, Nina Erwin, Yanjun Li, Zuo Ding, Tarun E Hutchinson, Hinrich Staecker, Mei He
Förderung
- NIGMS NIH HHS
- NIAID NIH HHS
- CFF
- NIH NIGMS
- PhRMA Foundation
- University of Florida Health Cancer Center GU pilot
Zitieren
APA
Pan, X., Huang, P., Ali, S. S., Renslo, B., Greenberg, Z., Erwin, N., Li, Y., Ding, Z., Hutchinson, T. E., Warnecke, A., Fernandez, N. E., Staecker, H., & He, M. (2025). Extracellular vesicle–mediated gene editing for the treatment of nonsyndromic progressive hearing loss in adult mice. Science Translational Medicine, 17(824). https://doi.org/10.1126/scitranslmed.adn3993
Vancouver
Pan X, Huang P, Ali SS, Renslo B, Greenberg Z, Erwin N, et al. Extracellular vesicle–mediated gene editing for the treatment of nonsyndromic progressive hearing loss in adult mice. Science Translational Medicine. 2025;17(824). doi:10.1126/scitranslmed.adn3993
BibTeX
@article{Pan2025,
author = {Pan, Xiaoshu and Huang, Peixin and Ali, Samantha S and Renslo, Bryan and Greenberg, Zachary and Erwin, Nina and Li, Yanjun and Ding, Zuo and Hutchinson, Tarun E and Warnecke, Athanasia and Fernandez, Natalia E and Staecker, Hinrich and He, Mei},
title = {Extracellular vesicle–mediated gene editing for the treatment of nonsyndromic progressive hearing loss in adult mice},
journal = {Science Translational Medicine},
year = {2025},
volume = {17},
number = {824},
doi = {10.1126/scitranslmed.adn3993}
}
EUVIMED